The impact of the duration of untreated psychosis on short- and long-term outcome in schizophrenia

Current Opinion in Psychiatry

Volumn 16, Issue SUPPL. 2, 2003, Pages

  Bottlender, Ronald ^a   Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

DUP; Early intervention; Neurotoxic processes; Outcome; Schizophrenia

Indexed keywords

CLINICAL FEATURE; COGNITION; DISEASE COURSE; HUMAN; MORBIDITY; NEUROTOXICITY; OUTCOMES RESEARCH; PSYCHOSIS; REVIEW;

EID: 0042744861     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200304002-00007     Document Type: Review

References (40)

1. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter Jr WT. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry 1990; 147:290-294.
2. Mueser KT, Douglas MS, Bellack AS, Morrison RL. Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull 1991; 17:565-582.
3. Bottlender R, Wegner U, Wittmann J, et al. Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 1999; 249 (Suppl 4):27-36.
4. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991; 17:325-351.
5. Wyatt RJ, Henter I. Rationale for the study of early intervention. Schizophr Res 2001; 51:69-76.
6. Angrist, B, Schulz SC, editors. Introduction to the neuroleptic-nonresponsive patient: characterization and treatment. Washington, DC: American Psychiatric Press; 1990.
7. Lieberman JA, Koreen AR, Chakos M, et al. Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 1996; 57 (Suppl 9):5-9.
8. Bottlender R, Jager M, Groll C, et al. Deficit states in schizophrenia and their association with the length of illness and gender. Eur Arch Psychiatry Clin Neurosci 2001; 251:272-278.
9. Loebel AD, Lieberman JA, Alvir JMJ, et al. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992; 149:1183-1188.
10. McEvoy JP, Schooler NR, Wilson WH. Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol Bull 1991; 27:97-101.
11. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000; 177:511-515.
12. Haas GL, Garratt LS, Sweeney JA. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998; 32:151-159.
13. Bottlender R, Strauss A, Möller HJ. Relation between duration of symptoms prior to admission and treatment response in 998 first admitted schizophrenic patients. Schizophr Res 2000; 44:145-150.
14. Black K, Peters L, Rui Q, et al. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001; 47:215-222.
15. Edwards J, Maude D, McGorry PD, et al. Prolonged recovery in first-episode psychosis. Br J Psychiatry 1998; 172 (Suppl 33):107-116.
16. McGorry PD, Edwards J, Mihalopoulos C, et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22:305-326.
17. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000; 45:1-9.
18. Malla AK, Norman RM, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002; 54:231-242.
19. Ho BC, Andreasen NC, Flaum M, et al. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157:808-815.
20. Craig TJ, Bromet EJ, Fennig S, et al. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157:60-66.
21. Amminger GP, Edwards J, Brewer WJ, et al. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr Res 2002; 54:223-230.
22. Scully PJ, Coakley G, Kinsella A, Waddington JL. Psychopathology executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med 1997; 27:1303-1310.
23. Barnes TR, Hutton SB, Chapman MJ, et al. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177:207-211.
24. Hoff AL, Sakuma M, Razi K, et al. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry 2000; 157:1824-1828.
25. Norman RM, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry 2001; 179:340-345.
26. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986; 148:120-127.
27. Rabiner CJ, Wegner JT, Kane JM. Outcome study of first-episode psychosis. I: Relapse rates after 1 year. Am J Psychiatry 1986; 143:1155-1158.
28. Altamura AC, Bassetti R, Sassella F, et al. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study. Schizophr Res 2001; 52:29-36.
29. Lo WH, Lo T. A ten-year follow-up study of Chinese schizophrenics in Hong Kong. Br J Psychiatry 1977; 131:63-66.
30. Helgason L. Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr Scand 1990; 81:231-235.
31. Inoue K, Nakajima T, Kato N. A longitudinal study of schizophrenia in adolescence. I. The one- to three-year outcome. Jpn J Psychiatry Neurol 1986; 40:143-151.
32. Moscarelli M, Capri S, Neri L. Cost evaluation of chronic schizophrenic patients during the first 3 years after the first contact. Schizophr Bull 1991; 17:421-426.
33. Moscarelli M. Health and economic evaluation in schizophrenia: implications for health policies. Acta Psychiatr Scand 1994; 89 (Suppl 382):82-88.
34. Carbone S, Harrigan S, McGorry PD, et al. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand 1999; 100:96-104.
35. Bottlender R, Sato T, Jäger M, et al. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia, Schizophr Res (in press).
36. Waddington JL, Youssef HA, Kinsella A. Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med 1995; 25:849-857.
37. Wyatt RJ, Green MF, Tuma AH. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychol Med 1997; 27:261-268.
38. May PR, Tuma AH, Dixon WJ, et al. Schizophrenia. A follow-up study of the results of five forms of treatment. Arch Gen Psychiatry 1981; 38:776-784.
39. DeLisi LE, Sakuma M, Tew W, et al. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997; 74:129-140.
40. Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001; 49:487-499.